Latest Capital Raises News

Page 182 of 445
Cynata Therapeutics reported a $9.39 million net loss for FY2025, slightly improved from the prior year, while progressing multiple clinical trials with key results expected in 2026. The company maintains a solid cash position and funding runway through mid-2026, supported by recent capital raises and an equity subscription agreement.
Ada Torres
Ada Torres
28 Aug 2025
Sparc Technologies reported a narrower FY25 loss alongside progress in green hydrogen and graphene additive projects, supported by government grants and a successful capital raise.
Victor Sage
Victor Sage
28 Aug 2025
Alexium International Group Limited posted a 42.2% increase in net loss for FY2025, with revenues down 33.4% due to a soft US mattress market. Despite financial setbacks, the company advanced key technologies and announced leadership changes that could fuel future growth.
Victor Sage
Victor Sage
28 Aug 2025
ARC Funds Limited posted a $2.45 million loss for FY2025, driven by strategic investments and increased transaction costs as it expands its funds management platform.
Claire Turing
Claire Turing
28 Aug 2025
Foresta Group Holdings reported a $3.375 million net loss for FY2025 while making significant progress on its Kawerau biomass facility in New Zealand, securing key approvals, partnerships, and funding. The company aims to commence construction in FY2026, positioning itself in the renewable energy sector.
Maxwell Dee
Maxwell Dee
28 Aug 2025
FortifAI Limited reported a 15% decline in game revenue to $4.3 million for FY2025 but achieved a significant 72% reduction in net loss to $1.99 million, supported by operational cost cuts and a $3.6 million capital raise.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Aurora Labs reported a 34% increase in loss after tax to $3.75 million for FY2025, alongside a 327% surge in revenue driven by defence contracts and 3D printing services. The company is progressing its micro gas turbine propulsion systems and pursuing aerospace certification to expand its market footprint.
Victor Sage
Victor Sage
28 Aug 2025
NeuroScientific Biopharmaceuticals reported a $1.85 million loss for FY25, driven by reduced R&D incentives and increased development costs following its acquisition of StemSmart™ technology. The company is advancing clinical programs, including a Special Access Scheme for Crohn’s disease.
Ada Torres
Ada Torres
28 Aug 2025
Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.
Ada Torres
Ada Torres
28 Aug 2025
Brazilian Critical Minerals Ltd has converted a significant portion of its outstanding debt into equity, issuing over 120 million shares to a key investor, while also raising a modest $50,000 through a new share placement to support working capital.
Maxwell Dee
Maxwell Dee
28 Aug 2025
HPP has agreed to acquire Red Earth Energy Storage in a $40 million merger, aiming to relist on the ASX by early 2026 and capitalize on Australia’s growing battery storage market.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Harris Technology Group reported a 17% revenue decline for FY25 but improved its net loss by nearly 32%, driven by a pivot towards higher-margin refurbished IT products and tighter inventory management.
Sophie Babbage
Sophie Babbage
28 Aug 2025